Cargando…
The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy
OBJECTIVE: Prevention of diabetic retinopathy would benefit from availability of drugs that preempt the effects of hyperglycemia on retinal vessels. We aimed to identify candidate drug targets by investigating the molecular effects of drugs that prevent retinal capillary demise in the diabetic rat....
Autores principales: | Gerhardinger, Chiara, Dagher, Zeina, Sebastiani, Paola, Park, Yong Seek, Lorenzi, Mara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699853/ https://www.ncbi.nlm.nih.gov/pubmed/19401417 http://dx.doi.org/10.2337/db08-1008 |
Ejemplares similares
-
Endothelial Progenitor Cells Carrying Monocyte Markers Are Selectively Abnormal in Type 1 Diabetic Patients With Early Retinopathy
por: Zerbini, Gianpaolo, et al.
Publicado: (2012) -
Patrolling Monocytes Are Recruited and Activated by Diabetes to Protect Retinal Microvessels
por: Tecilazich, Francesco, et al.
Publicado: (2020) -
IL-1β Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1β Autostimulation
por: Liu, Yang, et al.
Publicado: (2012) -
The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient
por: Lorenzi, Mara
Publicado: (2007) -
Is there a place for inhibition of transforming growth factor‐β and the polyol pathway in therapy for diabetic retinopathy?
por: Hotta, Nigishi
Publicado: (2010)